Related Experiment Video
Updated: May 6, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Systemic lupus erythmatosus - When to consider and management options
Diane Apostolopoulos1, Alberta Yik-Bun Hoi
1B BiomedSci, MBBS, Rheumatology Registrar, Department of Rheumatology, Monash Health, Melbourne, Victoria.
Abstract:
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterised by multi-system manifestations. It is regarded as the prototypal connective tissue disease, where the key pathogenesis relates to a dysfunctional immune system that results in over-production of various autoantibodies. Most of its pathology is mediated by either direct or indirect effects of these autoantibodies, as well as other components of the innate and adaptive immune systems.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Rheumatic Heart Disease III: Medical Management
Myocarditis IV: Nursing Management
Rheumatic Heart Disease IV: Nursing Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

